Zobrazeno 1 - 10
of 365
pro vyhledávání: '"Sun Min Lim"'
Autor:
Hee-Kyung HAN, Mi Hyun KIM, Seong Su JEONG, Dong Kwon KIM, Youngtaek KIM, Joon Yeon HWANG, Seong-san KANG, Seung Min YANG, Seul LEE, Sujeong BAEK, Kwangmin NA, Chai Young LEE, Yu Jin HAN, So Young PARK, Min Hee HONG, Jii Bum LEE, Sun Min LIM, Jae-Hwan KIM, Kyoung-Ho PYO, Byoung Chul CHO
Publikováno v:
Korean Journal of Clinical Laboratory Science, Vol 56, Iss 3, Pp 236-247 (2024)
The human leukocyte antigen (HLA) system, which is part of the major histocompatibility complex (MHC) plays a vital role in immune responses by differentiating between itself and foreign cells and antigens. The significant diversity of alleles affect
Externí odkaz:
https://doaj.org/article/859055acbde0481581dfddf810ccc1c2
Autor:
Miso Kim, Hyo Sup Shim, Sheehyun Kim, In Hee Lee, Jihun Kim, Shinkyo Yoon, Hyung-Don Kim, Inkeun Park, Jae Ho Jeong, Changhoon Yoo, Jaekyung Cheon, In-Ho Kim, Jieun Lee, Sook Hee Hong, Sehhoon Park, Hyun Ae Jung, Jin Won Kim, Han Jo Kim, Yongjun Cha, Sun Min Lim, Han Sang Kim, Choong-Kun Lee, Jee Hung Kim, Sang Hoon Chun, Jina Yun, So Yeon Park, Hye Seung Lee, Yong Mee Cho, Soo Jeong Nam, Kiyong Na, Sun Och Yoon, Ahwon Lee, Kee-Taek Jang, Hongseok Yun, Sungyoung Lee, Jee Hyun Kim, Wan-Seop Kim
Publikováno v:
Journal of Pathology and Translational Medicine, Vol 58, Iss 4, Pp 147-164 (2024)
In recent years, next-generation sequencing (NGS)–based genetic testing has become crucial in cancer care. While its primary objective is to identify actionable genetic alterations to guide treatment decisions, its scope has broadened to encompass
Externí odkaz:
https://doaj.org/article/44ffb81b584c45b583bff31f456ec2e9
Autor:
Jina Kim, Min Hee Hong, Hye Ryun Kim, Sun Min Lim, Chang Gon Kim, Da Hee Kim, Nam Suk Sim, Hyun Jun Hong, Yoon Woo Koh, Se-Heon Kim, Chan Woo Wee, Chang Geol Lee, Ki Chang Keum, Chang-Hoon Kim, Kyung Hwan Kim
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
BackgroundSinonasal squamous cell carcinoma (SCC) is a rare disease entity, comprising less than 5% of malignancies of the head and neck. While surgery is the primary treatment approach, neoadjuvant and adjuvant therapies play crucial roles in enhanc
Externí odkaz:
https://doaj.org/article/e2959e55792a4df09c9a5c12fd77623d
Autor:
Sun Min Lim, Stefanie S. Schalm, Eun Ji Lee, Sewon Park, Chiara Conti, Yves A. Millet, Rich Woessner, Zhuo Zhang, Luz E. Tavera-Mendoza, Faith Stevison, Faris Albayya, Thomas A. Dineen, John Hsieh, Seung Yeon Oh, Alena Zalutskaya, Julia Rotow, Koichi Goto, Dae-Ho Lee, Mi Ran Yun, Byoung Chul Cho
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 16 (2024)
Introduction: Despite the availability of several epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs), most patients with non-small-cell lung cancer (NSCLC) eventually develop resistance to these agents. Notably, EGFR _C797S mut
Externí odkaz:
https://doaj.org/article/a9dcec66ffca44c6854af71897c42a4e
Autor:
Dong Ki Lee, Sook Ryun Park, Yeul Hong Kim, Yun-Gyoo Lee, Su-Jin Shin, Beung-Chul Ahn, Sung Sook Lee, Sun Min Lim, Hye Ryun Kim, Byoung Chul Cho, Min Hee Hong
Publikováno v:
OncoImmunology, Vol 13, Iss 1 (2024)
Spartalizumab (PDR001) is a humanized IgG4 monoclonal antibody targeting programmed cell death protein 1 (PD-1). We conducted a single-arm, phase 2 trial to investigate the efficacy and safety of spartalizumab in patients with refractory esophageal s
Externí odkaz:
https://doaj.org/article/7b1070c787db4a9e95ccef4e55841573
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 16 (2024)
Background: Programmed death-ligand (PD-L1) expression serves as a predictive biomarker for immune checkpoint inhibitor (ICI) sensitivity in non-small cell lung cancer (NSCLC). Nevertheless, the development of biomarkers that reliably predict ICI res
Externí odkaz:
https://doaj.org/article/2591db794ac84f778d6314e2309f64b9
Autor:
Dong Kwon Kim, Chai Young Lee, Yu Jin Han, So Young Park, Heekyung Han, Kwangmin Na, Mi Hyun Kim, Seung Min Yang, Sujeong Baek, Youngtaek Kim, Joon Yeon Hwang, Seul Lee, Seong-san Kang, Min Hee Hong, Sun Min Lim, Jii Bum Lee, Jae Hwan Kim, Byoung Chul Cho, Kyoung-Ho Pyo
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
IntroductionAryl hydrocarbon receptor (AhR) is a transcription factor that performs various functions upon ligand activation. Several studies have explored the role of AhR expression in tumor progression and immune surveillance. Nevertheless, investi
Externí odkaz:
https://doaj.org/article/a3b7746f9d2b48d2b48f7c6bdb67e2a9
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 16 (2024)
Background: Identifying actionable driver mutations via tissue-based comprehensive genomic profiling (CGP) is paramount in treatment decisions for metastatic non-squamous, non-small-cell lung cancer (NSCLC). However, the role of CGP remains elusive i
Externí odkaz:
https://doaj.org/article/1ad401f8e1e84752b9834e7071188a70
Autor:
Kwangmin Na, Seul Lee, Dong Kwon Kim, Young Seob Kim, Joon Yeon Hwang, Seong-san Kang, Sujeong Baek, Chai Young Lee, Seung Min Yang, Yu Jin Han, Mi hyun Kim, Heekyung Han, Youngtaek Kim, Jae Hwan Kim, Seunghyun Jeon, Youngseon Byeon, Jii Bum Lee, Sun Min Lim, Min Hee Hong, Kyoung-Ho Pyo, Byoung Chul Cho
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
IntroductionTo understand the immune system within the tumor microenvironment (TME) of non-small cell lung cancer (NSCLC), it is crucial to elucidate the characteristics of molecules associated with T cell activation.MethodsWe conducted an in-depth a
Externí odkaz:
https://doaj.org/article/f13ad274bb6e438bb19dd14aedd7d16e
Autor:
Kyoo Hyun Kim1, Sun Min Lim1, Hee Kyung Ahn2, Yun-Gyoo Lee3, Keun-Wook Lee4, Myung-Ju Ahn5, Bhumsuk Keam6, Hye Ryun Kim1, Hyun Woo Lee7, Ho Jung An8, Jin-Soo Kim9 gistmd@gmail.com
Publikováno v:
Cancer Research & Treatment. Jan2024, Vol. 56 Issue 1, p37-47. 11p.